MedPath

University of Namibia

🇳🇦Namibia
Ownership
-
Established
1992-01-01
Employees
-
Market Cap
-
Website
http://www.unam.na

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia

Completed
Conditions
COVID-19
HIV Seropositivity
Tuberculosis, Pulmonary
Tuberculosis Infection
First Posted Date
2022-03-07
Last Posted Date
2024-10-24
Lead Sponsor
University of Namibia
Target Recruit Count
1750
Registration Number
NCT05268380
Locations
🇳🇦

University of Namibia, Windhoek, Namibia

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Recruiting
Conditions
Tuberculosis, Multidrug-Resistant
First Posted Date
2021-08-26
Last Posted Date
2024-10-24
Lead Sponsor
University of Namibia
Target Recruit Count
2100
Registration Number
NCT05022238
Locations
🇳🇦

University of Namibia, Windhoek, Namibia

News

No news found
© Copyright 2025. All Rights Reserved by MedPath